Thomas Fabre

Thomas Fabre

Cambridge, Massachusetts, United States
660 followers 500+ connections

About

Principal scientist in the fibrosis and innate immunity team

Activity

Join now to see all activity

Experience

  • Pfizer Graphic

    Pfizer

    Cambridge, Massachusetts, United States

  • -

    Cambridge, Massachusetts, États-Unis

  • -

    Cambridge, MA

  • -

    Cambridge, MA

  • -

  • -

  • -

    Région de Cannes, France

Education

  • Université de Montréal Graphic
  • -

    Étude in vitro de l’implication des cytokines de type Th17 dans la fibrose hépatique / In vitro study of Th17 cytokines implication in liver fibrosis

  • -

Publications

  • IL-17A Enhances the Expression of Profibrotic Genes through Upregulation of the TGF-β Receptor on Hepatic Stellate Cells in a JNK-Dependent Manner

    Journal of Immunology

    IL-17 producing cells, known as Th17 cells were implicated in several inflammatory conditions of the gut including liver fibrosis. In this paper, we demonstrate a potential mechanism for the role of IL-17 in enhancing liver fibrosis using an in vitro model of fibrosis through stimulation of the human hepatic stellate cell (HSC) line (LX2) and primary HSCs. We demonstrate that IL-17 alone has no direct effect on expression of the fibrogenic genes but increases their sensitivity to lower doses of…

    IL-17 producing cells, known as Th17 cells were implicated in several inflammatory conditions of the gut including liver fibrosis. In this paper, we demonstrate a potential mechanism for the role of IL-17 in enhancing liver fibrosis using an in vitro model of fibrosis through stimulation of the human hepatic stellate cell (HSC) line (LX2) and primary HSCs. We demonstrate that IL-17 alone has no direct effect on expression of the fibrogenic genes but increases their sensitivity to lower doses of the fibrogenic cytokine TGF-beta by upregulating and stabilizing the TGF-beta receptor on the surface of HSCs. More work examining the in vivo relevance of this observation is on going.

    Other authors
    See publication
  • Galectin-9 and IL-21 Mediate Cross-regulation between Th17 and Treg Cells during Acute Hepatitis C

    PloS Pathogens

    n this study, we investigated the mechanisms underlying failure of the CD4 helper T cell response during acute hepatitis C infection. We demonstrate that this failure is primarily due to loss of IL-21-producing CD4 T cells in individuals who progress towards chronic infection. This is accompanied by exhaustion of virus-specific cytotoxic CD8 T cells through upregulation of the exhaustion markers Tim-3, PD-1 and CTLA-4, higher plasma levels of the Tim-3 ligand Galectin-9 (Gal-9) and increased…

    n this study, we investigated the mechanisms underlying failure of the CD4 helper T cell response during acute hepatitis C infection. We demonstrate that this failure is primarily due to loss of IL-21-producing CD4 T cells in individuals who progress towards chronic infection. This is accompanied by exhaustion of virus-specific cytotoxic CD8 T cells through upregulation of the exhaustion markers Tim-3, PD-1 and CTLA-4, higher plasma levels of the Tim-3 ligand Galectin-9 (Gal-9) and increased frequency of Gal-9 producing regulatory T cells (Tregs). In vitro supplementation with IL-21 rescued HCV-specific CD8 T cells from Gal-9 induced apoptosis. Blocking Gal-9 expression in Tregs restored IL-21 production by virus-specific CD4 helper T cells. Altogether, our results suggest that failure of CD4 T cell help during acute HCV may be partially meditated by an imbalance between IL-21-producing CD4 T cells and Treg cells whereby exhaustion of both CD4 and CD8 T cells through the Tim-3/Gal-9 pathway is counteracted by IL-21.

    Other authors
    See publication
  • IL28B SNP Screening and Distribution in the French Canadian Population Using A Rapid PCR-based Test

    Immunogenetics (In Press)

    Jean-François Gélinas1,*, Thomas Fabre1,2, Philippe Willems1, Reynold C. Leung3, Jacob
    George3, Bernard Willems1,4, Julie Bruneau1,5 and Naglaa H. Shoukry1,4,†

    Other authors
    See publication

Honors & Awards

  • CIHR Gold medal

    CIHR

    Award for best presentation (Gold), 500CAD

  • CIHR Gold medal for best poster presentation

    CIHR

    500CAD

  • CIHR Ph.D fellowship

    CIHR

    35000CAD/yr

  • FRQS Ph.D fellowship

    FRQS

    Declined, ranked 1st.

  • Award for best poster- University of Montréal

    Université de Montréal

    150dollars

  • Bourse Ph.D du CRCHUM

    CRCHUM

    1000CAD

  • NCRTP Fellowship

    National CIHR Research Training Program (NCRTP) in Hepatitis C

    Annually, the NCRTP-HepC extends awards to provide transdisciplinary training and stipend support to both Canadian and foreign individuals involved with hepatitis C research, who are university graduates at various stages of their academic and professional career. This program and the stipends it provides are meant to further trainees' knowledge and understanding of hepatitis C.

    23000CAD/year

  • Premier prix pour présentation par affiche

    CRCHUM

    400dollars

  • Premier prix pour présentation orale

    FRSQ réseau SIDA/Mi

    500dollars

  • Troisiéme prix pour présentation orale

    FRSQ réseau SIDA/Mi

    150dollars

  • Bourse d'excellence de la FESP

    Faculté des études supérieures

    Financement de juin 2011 à juin 2012

  • Bourse d'excellence fondation Gabriel le marquis

    Fondation Gabriel le marquis

    Financement de juin 2011 à juin 2012

Languages

  • Français

    Native or bilingual proficiency

  • Anglais

    Full professional proficiency

  • Espagnol

    Elementary proficiency

More activity by Thomas

View Thomas’ full profile

  • See who you know in common
  • Get introduced
  • Contact Thomas directly
Join to view full profile

Other similar profiles

Explore collaborative articles

We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.

Explore More

Others named Thomas Fabre in United States

Add new skills with these courses